Diagnostic value of C-reactive protein test at early-onset sepsis in preterm infants

N Jincharadze1, D Abelashvili, M McHedlishvili

  • 1M. Iashvili Central PediatricClinic, Tbilisi, Georgia.

Georgian Medical News
|March 3, 2006
PubMed

Insights

C-reactive protein (CRP) is a rapid, sensitive marker for identifying early-onset sepsis in preterm infants. Elevated CRP levels indicate disease severity and can be a negative prognostic sign during treatment.

Area of Science:

  • Neonatal Medicine
  • Pediatric Infectious Diseases
  • Clinical Diagnostics

Background:

  • Bacterial sepsis poses a significant threat to preterm infants, necessitating rapid and accurate diagnostic tools.
  • Early identification of sepsis is crucial for timely intervention and improved outcomes in neonates.

Purpose of the Study:

  • To evaluate the significance of C-reactive protein (CRP) testing in identifying early-onset sepsis in preterm infants.
  • To assess the correlation between CRP levels and the severity of the infectious process.

Main Methods:

  • A study involving 250 preterm infants in a neonatal intensive care unit from 2002-2005.
  • C-reactive protein (CRP) levels were measured at 24, 48, and 72 hours postpartum using latex agglutination.
  • Infants were categorized into sepsis and non-sepsis groups based on CRP levels and hemoculture results.

Main Results:

  • Significantly elevated CRP levels were observed in infants diagnosed with early-onset sepsis compared to normal values.
  • A quantitative increase in CRP correlated with the severity of the sepsis.
  • Positive hemoculture confirmed sepsis diagnosis in the elevated CRP group, while normal CRP indicated its absence.

Conclusions:

  • Quantitative CRP levels serve as a rapid and sensitive diagnostic marker for early-onset sepsis in preterm infants.
  • Rising CRP levels during active sepsis therapy indicate a negative prognostic sign.
  • Monitoring CRP levels dynamically is recommended for assessing disease severity and guiding treatment.